Top Markets
Coin of the day
Asensus Surgical, Inc. Asensus Surgical, Inc.

Asensus Surgical, Inc.

ASXC
Rank in Stocks #22069
Asensus Surgical, Inc., a medical technology enterprise established in 2006 and... Asensus Surgical, Inc., a medical technology enterprise established in 2006 and headquartered in Durham, North Carolina, focuses on the research, development, and commercialization of robotic medical devices. Its core mission is to elevate minimally invasive surgical procedures throughout the United States, Europe, and Asia through innovative robotic solutions. The company's unique approach involves digitally bridging the gap between surgeons and patients, thereby introducing a new paradigm of "Performance-Guided surgery." This system aims to equip surgeons with critical clinical intelligence, ensuring consistently superior patient outcomes and setting a higher benchmark for surgical standards. Key products include the Senhance Surgical system, a multi-port robotic platform that can maneuver up to four arms to precisely control surgical instruments and a camera during laparoscopic operations. Their product line also features a range of specialized instruments, such as 3mm diameter instruments, 3mm and 5mm hooks, and articulating tools. Additionally, they offer the Senhance ultrasonic system, an advanced energy device designed for accurate, controlled tissue ligation and division. The company, initially known as TransEnterix, Inc., officially rebranded to Asensus Surgical, Inc. in February 2021.
Share Price
$0.3479
Last synced: 2024-08-21
Market Cap
$94.92M
Change (1 day)
0.64%
Change (1 year)
0.00%
Country
US
Trade Asensus Surgical, Inc. (ASXC)

Category

P/E ratio for Asensus Surgical, Inc. (ASXC)
P/E ratio as of August 2026 TTM: -1.12
According to Asensus Surgical, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.12. At the end of 2022 the company had a P/E ratio of -1.09.
P/E ratio history for Asensus Surgical, Inc. from 2000 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
2026 (TTM) -1.12 10.03%
2023 -1.02 -6.55%
2022 -1.09 -73.06%
2021 -4.03 436.27%
2020 -0.75 344.77%
2019 -0.17 -97.77%
2018 -7.58 -70.59%
2017 -25.77 63.11%
2016 -15.80 -71.10%
2015 -54.68 -7.31%
2014 -58.99 145.02%
2013 -24.08 2,000.38%
2012 -1.15 -93.96%
2011 -18.97 -59.05%
2010 -46.32 -24.93%
2009 -61.70 138.25%
2008 -25.90 -79.37%
2007 -125.51 697.41%
2006 -15.74 -93.04%
2005 -226.30 734.28%
2004 -27.13 144.54%
2003 -11.09 491.04%
2002 -1.88 -103.36%
2001 55.84 240.83%
2000 16.38 0.00%
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
35.77 -3,287.64%
US
34.86 -3,206.33%
US
21.39 -2,005.71%
IE
20.90 -1,962.18%
US
- -
DE
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.